Investigative Techniques

51 trials 31 recruiting

Filter these 51 trials by phase, country and sponsor.

Open in Search →

The Neurobiological Effect of 5-HT2AR Modulation Recruiting

2024-515961-33-00 No medical conditions or diseases will be examined, onl 3 2024-09-02
Optimizing treatment strategy in axial spondyloarthritis by molecular imaging with Technetium-labeled certolizumab pegol. Recruiting

2023-505694-32-00 Axial Spondyloarthritis 5 2024-08-29
IMPROCAS - Improved Prediction of Ovarian Cancer Surgery Recruiting

2023-503398-39-00 Ovarian cancer 4 2024-03-01
[18F]AlF-PSMA-11 PET in advanced thyroid and head and neck carcinoma Recruiting

2022-503036-13-00 Head and neck squamous cell carcinoma, thyroid carcinom 4 2024-02-01
Prospective head-to-head comparison of cardiac [18F]-MFBG PET versus [123I]-MIBG SPECT in the differentiation between Parkinson’s disease an… Recruiting

2023-506508-18-00 Parkinson's disease 10 2024-01-19
FAPi-PET imaging of in vivo early fistula healing in perianal Crohn’s disease: PERSIST study Recruiting

2023-505317-25-00 perianal Crohn's fistula 6 2023-11-24
Early detection of hepatocellular carcinoma by Hyperpolarized [1- 13C]pyruvate MRI Recruiting

2024-512490-27-00 Primary liver cancer 4 2023-06-19
Immune-Related Rheumatological and neurological Adverse Events study. Recruiting

2024-516631-27-00 Cancer (all types) 4 2023-05-05
Pneumococcal vaccine response in lymph nodes Recruiting

2022-501519-15-00 Healthy volunteers 4 2023-04-01
Randomized clinical trial to evaluate the utility of CYP2D6 genotyping to improve the efficacy and safety of tramadol in the treatment of ac… Recruiting

2022-500377-13-01 Pharmakogenetics 6 2022-10-05
Phase IIa Clinical Trial: Feasibility Study on Non-Invasive Simultaneous Hyperpolarized [1-13C]Pyruvate Magnetic Resonance Spectroscopy and … Recruiting

2024-516131-28-00 Breast cancer, neuroendocrine neoplasms, lymphomas, sar 4 2022-04-18
Benefit of positons emission tomography / 68Gallium citrate tomodensitometry for artificial hip and knee chronic infection diagnosis Recruiting

2024-515781-13-00 Prosthetic joint infection 4 2022-02-02
MRI of Neurometabolic Impairment in ALS and TIA Using Hyperpolarized Pyruvate Recruiting

2024-516954-24-00 ALS (Amyotrophic Lateral Sclerosis) 4 2020-05-01
Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease Ended

2022-502512-36-00 Progressive Fibrosing Interstitial Lung Diseases 4 2023-10-02
Randomized phase 2 trial of two chemotherapy regimens plus or minus bevacizumab in patients with well differentiated pancreatic neuroendocri… Ended

2023-505286-84-00 Pancreatic well differentiated neuroendocrine tumors (N 4 2018-06-25
Sentinel lymph node (SLN) detection in early oral cancer using Gallium-68-Tilmanocept PET/CT. Suspended

2025-521682-27-00 Oral cancer 11
A phase III, international, multiCenter, randomized, paraLlel-group, Endoscopist-blinded non-inferiority study of the efficAcy, safety and p… Ended

2025-521451-23-00 Subjects scheduled for elective colonoscopy performed a 5 2025-09-03
A Study to assess the safety and potential use of GEH121224 (18F) Injection to visualise HER2-Receptor expression using PET imaging in patie… Ended

2023-507720-23-00 Metastatic breast cancer 9 2024-11-15
Intradermal LPS to study vascular responses Ended

2024-512377-27-00 Immunological/cardiovascular conditions 3 2024-05-28
SAD and MAD study of VES001 Ended

2023-505847-38-00 Frontotemporal dementia (FTD) 1 2023-10-11
68Ga satoreotide trizoxetan PET/CT in patients with high grade neuroendocrine lung cancer Ended

2023-503362-24-01 large cell neuroendocrine lung cancer 4 2023-08-09
Transcranial Magnetic Stimulation (TMS) Evaluation of Central Nervous System (CNS) Pharmacodynamic (PD) Activity of Brexanolone in Healthy M… Ended

2022-503019-40-00 NA, PD study in Healthy Volunteers 3 2023-05-11
A positron emission tomography (PET) study to assess where the radiotracer [11C]AZ14132516 goes in the body following administration to heal… Ended

2022-502843-36-00 Crohn's disease 1 2023-04-27
Study of exposure to substances prohibited by the World Anti-Doping Agency in healthy volunteers. Proof of concept. Ended

2022-502216-36-00 Healthy volunteers 3 2023-02-27